[Pulmonary calcified micronodules]

Same author

Integrated inference of cancer gene expression from cell-free plasma chromatin.

bioRxiv : the preprint server for biology·2026

Same author

[Impact of digital technology and artificial intelligence on the training of pathology residents: Benefits, limitations, and educational prospects].

Annales de pathologie·2026

Same author

Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Same author

MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial.

Translational oncology·2025

Same journal

[Case no. 2. Pseudotumoral pulmonary IgG4 disease].

Annales de pathologie·2026

Same journal

[Diffuse large B-cell lymphoma-NOS , high-grade B-cell lymphomas and Burkitt lymphoma: Updates].

Annales de pathologie·2026

Same journal

[Ironing out the diagnosis].

Annales de pathologie·2026

Same journal

[Ecological transformation and quality of surgical pathological analysis: Not such an insoluble equation].

Annales de pathologie·2026

Same journal

[Cerebrospinal fluid in the context of headaches with decreased visual acuity].

Annales de pathologie·2026

Same journal

[Facial granulomatous lesion in a traveler].

Annales de pathologie·2026

Related Experiment Videos

[Pulmonary calcified micronodules]

Related Concept Videos

Integrated inference of cancer gene expression from cell-free plasma chromatin.

[Impact of digital technology and artificial intelligence on the training of pathology residents: Benefits, limitations, and educational prospects].

Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.

Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial.

[Case no. 2. Pseudotumoral pulmonary IgG4 disease].

[Diffuse large B-cell lymphoma-NOS , high-grade B-cell lymphomas and Burkitt lymphoma: Updates].

[Ironing out the diagnosis].

[Ecological transformation and quality of surgical pathological analysis: Not such an insoluble equation].

[Cerebrospinal fluid in the context of headaches with decreased visual acuity].

[Facial granulomatous lesion in a traveler].

Related Experiment Videos

[Pulmonary calcified micronodules]

Related Concept Videos

Related Articles

Integrated inference of cancer gene expression from cell-free plasma chromatin.

[Impact of digital technology and artificial intelligence on the training of pathology residents: Benefits, limitations, and educational prospects].

Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.

Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial.

[Case no. 2. Pseudotumoral pulmonary IgG4 disease].

[Diffuse large B-cell lymphoma-NOS , high-grade B-cell lymphomas and Burkitt lymphoma: Updates].

[Ironing out the diagnosis].

[Ecological transformation and quality of surgical pathological analysis: Not such an insoluble equation].

[Cerebrospinal fluid in the context of headaches with decreased visual acuity].

[Facial granulomatous lesion in a traveler].